The study was executed in 2 phases – quantitative followed by qualitative.
Length of Interview of the quantitative survey: 30 minutes
Length of Interview of the qualitative survey: 60 minutes
Target markets: UK and EU4
The surveys consisted of questions divided into different sections:
Epilepsy patient management (process of treatment decision, treatment lines and switching process).
Patient journey and challenges (impact of epilepsy in patient’s life, financial burden and associated care)
Treatment trend (switch from the 3rd generation to 4th generation drugs, shift from originators to generics and vice versa, challenges faced on treatment shift, patient’s response).
Overall disease burden and treatment decision drivers.
We deployed a specialist team of healthcare researchers, comprised of experienced Research analysts with skillsets for healthcare discussion with specialists and project managers with experience in data analysis